KUBUŠ, Peter, Pavel VÍT, Roman A. GEBAUER, Libor ZAORAL, Petr PEICHL, Martin FIALA a Jan JANOUŠEK. Long-term results of paediatric radiofrequency catheter ablation: a population-based study. Europace. Oxford: Oxford University Press, 2014, roč. 16, č. 12, s. 1808-1813. ISSN 1099-5129. Dostupné z: https://dx.doi.org/10.1093/europace/euu087.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Long-term results of paediatric radiofrequency catheter ablation: a population-based study
Autoři KUBUŠ, Peter (203 Česká republika), Pavel VÍT (203 Česká republika, garant), Roman A. GEBAUER (276 Německo), Libor ZAORAL (203 Česká republika), Petr PEICHL (203 Česká republika), Martin FIALA (203 Česká republika, domácí) a Jan JANOUŠEK (203 Česká republika).
Vydání Europace, Oxford, Oxford University Press, 2014, 1099-5129.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.670
Kód RIV RIV/00216224:14110/14:00077658
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1093/europace/euu087
UT WoS 000347104900022
Klíčová slova anglicky Radiofrequency ablation; Children; Tachycardia; Congenital heart disease; Paediatric
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 10. 2. 2015 11:25.
Anotace
Aims: We aimed to evaluate long-term utilization and results of paediatric radiofrequency catheter ablation (RFCA) in a population-based study. Methods: and results Data from all three centres performing paediatric RFCA for the whole population of the Czech Republic between 1993 and 2010 were retrospectively reviewed. A total of 708 ablation procedures in 633 consecutive patients <18 years for 716 different substrates were tracked, with accessory pathways = 439 (61.3%) and atrioventricular nodal reentry tachycardia (AVNRT) = 205 (28.6%) being most frequent. Incidence of RFCA reached 0.049 per 1000 children <18 years of age in the recent era (2006–10). Indications included patient preference (68.0%), drug refractoriness (15.5%), asymptomatic Wolff–Parkinson–White pre-excitation (8.4%), and malignant arrhythmia (6.1%). Median follow-up was 13.7 (interquartile range 5.7–21.5) months. Overall acute/long-term success of the primary procedure was 89.1/77.2% (accessory pathways 87.2/77.7%, AVNRT 98.5/84.4%). Re-ablation was performed in 73 of 163 substrates after a primary unsuccessful ablation resulting in a long-term cumulative efficacy of 96.3%. Between 1993–2005 and 2006–10, procedure/fluoroscopy time decreased from median 154/24 to 105/14 min. (P < 0.001 for both). Serious complications occurred in nine patients (1.4%). Conclusion: This population-based study could replicate data from previous single- or multi-centre reports confirming RFCA as a safe method of arrhythmia treatment in children with long-term cumulative efficacy exceeding 90% and significant decrease in the procedure and fluoroscopy time during the study period. The need for RFCA can be estimated at 0.05/1000 children <18 years using current indication criteria.
VytisknoutZobrazeno: 27. 4. 2024 06:56